Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.22 USD | +3.67% | +9.70% | -3.57% |
May. 20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
May. 06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Foghorn Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Foghorn Therapeutics Inc.
Morgan Stanley | |
Goldman Sachs | |
Wedbush | |
HC Wainwright | |
BMO Capital | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- FHTX Stock
- Consensus Foghorn Therapeutics Inc.